Changes in presenilin 2-binding Wnt proteins, behavior, amyloid-Β 42, γ-secretase activity, and testosterone sensitivity in transgenic mice coexpressing tetracycline-controlled transactivator and human mutant presenilin 2

NeuroMolecular Medicine

Volumn 8, Issue 3, 2006, Pages 415-431

  Hwang, Dae Y ^a   Cho, Jung S ^a   Kim, Chuel K ^a   Shim, Sun B ^a   Jee, Seung W ^a   Lee, Su H ^a   Seo, Su J ^a   Choi, Soo Y ^a   Kim, Yong K ^a  

^a Korea Food and Drug Administration   (South Korea)

Author keywords

Alzheimer's disease; GSK; Presenilin 2; Tau; Tetracycline

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; DOXYCYCLINE; GAMMA SECRETASE; PRESENILIN 2; TESTOSTERONE; TRANSACTIVATOR PROTEIN; WNT PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; CASTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE INDUCTION; HORMONE SENSITIVITY; HUMAN; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REPRESSOR GENE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 33745254478     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:8:3:415     Document Type: Article

References (41)

1. Borchelt D. R., Thinakaran G., Eckman C. B., et al. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
2. Citron M., Westaway D., Xia W., et al. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β protein in both transfected cell and transgenic mice. Nat. Med. 3, 67-72.
3. Corder E. H., Saunders A. M., Strittmatter W. J., et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 828-829.
4. Dale T. C. (1998) Signal transduction by Wnt family of ligands. Biochem. J. 15, 209-223.
5. De Ferrari G. V., Chacon M. A., Barria M. I., et al. (2003) Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol. Psychiatry 8, 195-208.
6. De Strooper B., Annaert W., Cupers P., et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch interacellular domain. Nature 398, 518-522.
7. Doble B. W. and Woodgett J. R. (2003) GSK3: tricks of the trade for a multitasking kinase. J. Cell Sci. 116, 1175-1186.
8. Duff K., Eckman C., Zehr C., et al. (1996) Increased amyloid β-42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
9. Forss S., Danielson P. E., Catsicas S., et al. (1990) Transgenic mice expressing β-galactosidase in mature neuron under neuron-specific enolase promoter control. Cell 5, 187-197.
10. Hwang D. Y., Cho J. S., Chae K. R., et al. (2003) Differential expression of the tetracycline-controlled transactivator-driven human CYP1B1 gene in double-transgenic mice is due to androgens: application for detecting androgens and antiandrogens. Arch. Biochem. Biophys. 415, 137-145.
11. Hwang D. Y., Chae K. R., Kang T. S., et al. (2002) Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J. 16, 805-813.
12. Hwang D. Y., Cho J. S., Lee S. H., et al. (2004) Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw. Exp. Neurol. 186, 20-32.
13. Janicki S. and Monteiro M. J. (1997) Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I). J. Cell Biol. 139, 485-495.
14. Kim Y. K. and Ogita Z. (1981) Sexual dimorphism of SDS-peptide patterns from submaxillary gland of mice. J. Exp. Zool. 218, 447-453.
15. Kim T. W., Pettingell W. H., Hallmark O. G., et al. (1997a) Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272, 11,006-11,010.
16. Kim T. W., Pettingell W. H., Jung Y. K., et al. (1997b) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373-376.
17. Kuo Y. M., Emmerling M. R., Vigo-Pelfrey C., et al. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077-4081.
18. Levy-Lahad E., Wasco W., Poorkaj P., et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
19. Lim H. J., Cho J. S., Oh J. H., et al. (2005) NSE-controlled carboxyl-terminus of APP gene overexpressing in transgenic mice induces altered expression in behavior, Aβ-42, and GSK3β binding proteins. Cell Mol. Neurobiol. 25, 833-850.
20. Loetscher H., Deuschle U., Brockhaus M., et al. (1997) Presenilins are processed by caspase-type proteases. J. Biol. Chem. 272, 20,655-20,659.
21. Lue L. F., Kuo Y. M., Roher A. E., et al. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862.
22. Martin D. I. and Whitelaw E. (1996) The vagaries of variegating transgenes. Bioassay 18, 919-923.
23. McLean C. A., Cherny R. A., Fraser F. W., et al. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860-866.
24. Morris R. G. M., Garrud P., Rawlins J. N. P., et al. (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683.
25. Murayama M., Tanake S., Palacino J., et al. (1998) Direct association of presenilin-1 with beta-catenin. FEBS Lett. 433, 73-77.
26. Naslund J., Haroutunian V., Moshs R., et al. (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. J. Am. Med. Assoc. 283, 1571-1577.
27. Nusse R. (1999) WNT targets. Repression and activation. Trends Genet. 15, 1-3.
28. Oyama F., Sawamura N., Kobayashi K., et al. (1998) Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain. J. Neurochem. 71, 313-322.
29. Rogaev E. I., Sherrington R., Rogaeva E. A., et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
30. Sawamura N., Morishima-Kawashima M., Waki H., et al. (2000) Mutant presenilin 2 transgenic mice. A large increase in the levels of Abeta 42 is presumably associated with the low density membrane domain that contains decreased levels of glycerophospholipids and sphingomyelin. J. Biol. Chem. 275, 27,901-27,908.
31. Scheuner D., Eckman C., Jensen M., et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
32. Sherrington R., Rogaev E., Liang Y., et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
33. Selkoe D. J. and Wolfe M. S. (2000) In search of gamma-secretase: presenilin at the cutting edge. Proc. Natl. Acad. Sci. USA 97, 5690-5692.
34. Sisodia S. S., Annaert W., Kim S. H., et al. (2001) Gamma-secretase: never more enigmatic. Trends Neurosci. 24, 2-6.
35. Takashima A., Honda T., Yasutake K., et al. (1998a) Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 31, 317-323.
36. Takashima A., Murayama M., Murayama O., et al. (1998b) Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. USA 95, 9637-9641.
37. Tsien J. Z., Huerta P. T., and Tonegawa S. (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87, 1327-1338.
38. Walker E. S., Martinez M., Brunkan A. L., et al. (2005) Presenilin 2 familial Alzheimer's disease mutation in partial loss of function and dramatic changes in Abeta 42/40 ratios. J. Neurochem. 92, 294-301.
39. Xia W., Ostaszewski B. L., Kimberly W. T., et al. (2000) FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex. Neurobiol. Dis. 7, 673-681.
40. Yu G., Chen F., Levesque G., et al. (1998) The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J. Biol. Chem. 273, 16,470-16,475.
41. Zhang Z., Hartmann H., Do V. M., et al. (1998) Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395, 698-702.